^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

EGFR806-specific CAR T-cell therapy

i
Other names: EGFR806-specific chimeric antigen receptor (CAR) T cell therapy, second generation 4-1BBζ EGFR806-EGFRt, EGFR806-specific CAR T-cell therapy
Company:
Cellevolve Bio, Seattle Children's Hospital, Seattle Children’s Therapeutics
Drug class:
EGFR-targeted CAR-T immunotherapy